Cysteine-rich protein 1 (CRIP1)

Cysteine-rich protein 1 (CRIP1) is a small, highly conserved **zinc-binding protein** in the LIM/double zinc finger protein family, encoded by the *CRIP1* gene. CRIP1 contains a single LIM domain with characteristic zinc finger motifs, enabling it to bind metal ions, particularly zinc, contributing to its roles in regulating **cellular differentiation, proliferation, apoptosis, autophagy, and immune responses**. It is most highly expressed in the small intestine, lung, and immune cells such as monocytes and Paneth cells. CRIP1 is implicated in several cellular signaling pathways, including Wnt/β-catenin, PI3K-Akt, and NF-κB, where it can promote tumor progression, epithelial-mesenchymal transition, and immune modulation. Aberrant expression or epigenetic deregulation of CRIP1 is associated with multiple cancers, and it plays context-dependent roles as either an oncogene or a tumor suppressor depending on tissue type. Elevated CRIP1 is linked to chemoresistance, notably via proteasome and autophagy regulatory axes, impacting therapeutic outcomes. Beyond oncology, it functions as a biomarker in cardiovascular and immune-mediated diseases[1][2][3][4].

Other names

Cysteine-rich intestinal proteinCRIPCRP1CRHPcysteine-rich heart proteincysteine-rich intestinal proteincysteine-rich protein 1 (intestinal)

No direct-acting drugs; chemoresistance via enhanced proteasome activity and autophagy; modulation of PI3K-Akt, Wnt/β-catenin, JAK/STAT, TNFα-NFκB signaling pathways